CB Therapeutics is a biotech company that specializes in the biosynthetic production of cannabinoids from sugar.
CB Therapeutics's investors include Y Combinator, Pioneer Fund, Mystic Ventures, LYVC, EvoNexus.
CB Therapeutics is headquartered in La Jolla, United States.
CB Therapeutics is a biotech company that specializes in the biosynthetic production of cannabinoids from sugar.
CB Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CB Therapeutics — Funding & Investors." VCBacked, October 1, 2022, https://www.vcbacked.co/company/cb-therapeutics. Accessed August 17, 2026.
VCBacked. (2022). CB Therapeutics — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/cb-therapeutics
{{cite web |title=CB Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cb-therapeutics |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated